{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:55:36Z","timestamp":1791939336866,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clinthera.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T22:31:13Z","timestamp":1614292273000},"page":"e97-e110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019"],"prefix":"10.1016","volume":"43","author":[{"given":"Christopher","family":"Oddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Allington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanuja","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neesha","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwani","family":"Mawella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.02.004_bib0001","year":"2020"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamainternmed.2020.2306","article-title":"Assessment of deaths from COVID-19 and from seasonal influenza","volume":"180","author":"Faust","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0003","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0004","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0006","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14779072.2020.1826308","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis","volume":"18","author":"Lo","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0007","article-title":"The effect of prior ACEI\/ARB treatment on COVID-19 susceptibility and outcome: a systematic review and meta-analysis","author":"Xu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0008","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0009","first-page":"1","article-title":"Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study","volume":"21","author":"Yahyavi","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001353","article-title":"Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis","volume":"7","author":"Ssentongo","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0012","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jmv.26625","article-title":"The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0013","article-title":"The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19","volume":"31","author":"Braude","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0014","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/jmv.26588","article-title":"Association of renin-angiotensin-aldosterone system inhibitors with mortality and testing positive of COVID-19: meta-analysis","volume":"93","author":"Yokoyama","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","article-title":"Continued In-hospital angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use in hypertensive COVID-19 patients is associated with positive clinical outcome","volume":"222","author":"Lam","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0016","first-page":"85","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0017","unstructured":"National Early Warning Score (NEWS) 2: Royal College of Physicians; 2017 [updated December 19th]. Available from: https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/national-early-warning-score-news-2."},{"key":"10.1016\/j.clinthera.2021.02.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2016-000170","article-title":"British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings","volume":"4","author":"O'Driscoll","year":"2017","journal-title":"BMJ Open Respiratory Research"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0019","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.annemergmed.2003.08.008","article-title":"Nontraumatic out-of-hospital hypotension predicts inhospital mortality","volume":"43","author":"Jones","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/emermed-2018-207502","article-title":"The association between systolic blood pressure and in-hospital mortality in older emergency department patients who are hospitalised with a suspected infection","volume":"35","author":"Warmerdam","year":"2018","journal-title":"Emerg Med J"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0021","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0022","first-page":"321","article-title":"[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]","volume":"21","author":"Verdecchia","year":"2020","journal-title":"G Ital Cardiol (Rome)"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0023","series-title":"Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID) ClinicalTrials.gov","author":"Cohen","year":"2020"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","article-title":"Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2014the BRACE CORONA Trial","volume":"226","author":"Lopes","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0025","series-title":"Effects of discontinuing renin-angiotensin system inhibitors in patients with COVID-19 EU Clinical Trials Register","author":"Knop","year":"2020"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0026","series-title":"COVID-19\u2014ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection: the randomized ACORES-2 study EU Clinical Trials Register","author":"Vandenabele","year":"2020"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0027","series-title":"Stopping ACE-inhibitors in COVID-19\u2014a randomized, controlled clinical trial EU Clinical Trials Register","author":"Bauer","year":"2020"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0029","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2215\/CJN.14021118","article-title":"Stopping RAS inhibitors to minimize AKI: more harm than good?","volume":"14","author":"Tomson","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2021.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:54:12Z","timestamp":1758963252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0149291821001016"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.02.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}